Avantor (AVTR) Stock Forecast: StockMap's 2-Week Call

AVTR stock forecast: StockMap's model makes no two-week call on Avantor after the Nov 13 close: its evidence is split, 6 reasons for and 9 against. Too few two-week windows graded to judge yet.

Avantor last closed at $15.54, -0.51% on the session.

Against the IVW growth benchmark the position is +0.40% over the forecast window.

Avantor's market cap is $10.53B as of November 13, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 13 (too close to call).

Where AVTR sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 40%.

14 daily calls for AVTR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Avantor in the 26th percentile on valuation and the 50th percentile on return on equity, where 100 is best.

Avantor is classified under Health Care / Life Sciences Tools & Services.

StockMap tracks Avantor as the 16th largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 25 Neutral, 13 Moderate Outperform, 3 Moderate Underperform and 1 Strong Underperform.

On that composite Avantor ranks 19th of 42 in the group, against a group median of +0.13.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Avantor (AVTR) — StockMap 2-week forecast & tracked accuracy